Hubei Guangji Pharmaceutical Co.,Ltd. Posted 45.4 Million Yuan Net Loss in First Quarter of 2023

Hubei Guangji Pharmaceutical Co.,Ltd. (湖北广济药业股份有限公司) (000952.SZ) reported a net loss of 45.4 million yuan in the first quarter of 2023, reversing a net profit of 7.7 million yuan for the same period in the previous year.

Meanwhile, the company posted 115.3 million yuan in revenue, down 13.5% year-on-year.

At the end of the reporting period, it had 2.5 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 41%.